CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today. Total revenues increased 11% year-over-year to $80.6 billion. Net income rose to $2.9 billion, or $2.23 per share, from $2.7 billion, or $2.10 per share, in the year-ago quarter. Adjusted EPS amounted to $2.40. For full-year 2022, adjusted EPS is expected to be […]
CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today. Total revenues increased 11% year-over-year to $80.6 billion. Net income rose to $2.9 billion, or $2.23 per share, from $2.7 billion, or $2.10 per share, in the year-ago quarter. Adjusted EPS amounted to $2.40. For full-year 2022, adjusted EPS is expected to be […]
CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today.
Total revenues increased 11% year-over-year to $80.6 billion.
Net income rose to $2.9 billion, or $2.23 per share, from $2.7 billion, or $2.10 per share, in the year-ago quarter. Adjusted EPS amounted to $2.40.
For full-year 2022, adjusted EPS is expected to be $8.40-8.60.
